AKT1 and cancer: Overall, ampelopsin exerts great anti-tumorigenic effects on cell proliferation and metastasis through regulating the miR-21/PTEN/Akt pathway and miR-455–3p/ZEB1/PI3K/Akt pathway (Fig. 6) in CCA, which provides an alternative option for the future treatment of cancer.